DUBLIN, April 2, 2013 /PRNewswire/ --
Research and Markets has announced the addition of the "Blood Glucose Testing and Diabetes Management" report to their offering.
(Photo: http://photos.prnewswire.com/prnh/20130307/600769 )
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease - sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes - the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes, particularly Type 2 diabetes, among adults across the world. As such, the global market for blood glucose testing products is undergoing a significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. Although the blood glucose testing segment of the in vitro diagnostics (IVD) industry is mature, certain segments of the market, such as home testing devices for diabetes management, will exhibit strong growth. What's more, non-invasive testing now represents a major new area for the application of IVD testing. Additionally, direct access testing - or over-the-counter testing, which allows consumers to order tests themselves without visiting a doctor`- has emerged as a strong force in the blood glucose testing segment.
The purpose of this TriMark Publications report is to describe the specific market segments for blood glucose testing and diabetes management. This study reviews all of the generally-accepted clinical analytical methods that are currently in use today for measuring serum or plasma or whole-blood glucose concentrations. Moreover, it examines clinical measurement devices, reagents and supplies as utilized in hospitals, clinics, doctor's offices and at-home care locations.
Key Topics Covered:
1. Overview
2. Diabetes
3. Market Analysis: Size, Growth, Share and Competitors
4. Glucose Diagnostic and Monitoring Recommendations
5. Glucose Testing Technology Platforms and Consumable Products
6. Glucose Testing Devices on the Market
7. Business Trends in Glucose Testing
8. Technology Trends
9. Company Profiles
Companies Mentioned:
- Abaxis, Inc.
- Abbott Laboratories
- ACON Laboratories
- AgaMatrix
- Alere
- All Medicus
- Amedica Biotech
- A. Menarini Diagnostics
- Apex Biotechnology Corporation
- ARKRAY
- Bayer
- B. Braun Melsungen
- Beckman Coulter
- Bionime
- Bio-Rad Laboratories, Inc.
- BioTex
- Calisto Medical
- Cambridge Sensors
- DexCom
- Diagnostic Devices/Prodigy Diabetes Care
- DiaSys
- Echo Therapeutics
- Entra Health Systems
- Fora Care
- Genesis Health Technologies
- GenExel-Sein
- GlucoPlus
- GluMetris
- GlySens
- Hainice Medical
- HemoCue (a Quest Diagnostics company)
- Home Diagnostics
- Infopia
- IN4 Technology
- International Techidyne Corporation (ITC)
- Instrumentation Laboratory Company
- i-Sens
- Johnson & Johnson
- Luminous Medical
- Medtronic
- Nipro Corporation
- Nova Biomedical
- OrSense
- Polymer Technology Systems
- Radiometer Medical
- Roche
- 77 Elektronika Kft.
- Siemens AG
- Smiths Group
- Stanbio Laboratory
- TaiDoc Technology
- Techno Medica Co., Ltd.
- US Diagnostics
- VeraLight
For more information visit http://www.researchandmarkets.com/research/j49msm/blood_glucose
Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets